Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial	Resectable Pancreatic Adenocarcinoma	Recruiting	Phase 2	2025-02-20		NCT06816914

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chang Gung Memorial Hospital	214
China Medical University Hospital	112
Kaohsiung Medical University Chung-Ho Memorial Hospital	56
National Cheng-Kung University Hospital	83
National Taiwan University Hospital	540
Taichung Veterans General Hospital	63
Taipei Veterans General Hospital, Taiwan	80
Tri-Service General Hospital (TSGH)	36

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
China Medical University Hospital	Taichung	Taiwan	54
Kaohsiung Chang Gung Memorial Hospital	Kaohsiung City	Taiwan	18
Kaohsiung Medical University Chung-Ho Memorial Hospital	Kaohsiung City	Taiwan	48
Linkou Chang Gung Memorial Hospital	Taoyuan	Taiwan	7
National Cheng Kung University Hospital	Tainan	Taiwan	53
National Taiwan University Hospital	Taipei	Taiwan	203
Taichung Veterans General Hospital	Taichung	Taiwan	46
Taipei Veterans General Hospital	Taipei	Taiwan	64
Tri-Service General Hospital	Taipei	Taiwan	27